Neurogranin (Ng) - Synaptic Biomarker

Neurogranin (Ng)

Neurogranin (Ng) is a postsynaptic neuronal protein that serves as a sensitive biomarker for synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders[@portelius2015].

Overview

Neurogranin is a 78-amino acid protein encoded by the RC3 (RC3/Ng) gene, also known as neurogranin or RC3. It is highly enriched in dendritic spines of excitatory neurons in the hippocampus and cerebral cortex[@dazmoreno2010]. As a biomarker, neurogranin reflects the loss of synaptic integrity, which is a hallmark of cognitive decline in neurodegenerative diseases.

Structure and Function

Molecular Characteristics

| Property | Value |
|----------|-------|
| Gene | RC3 (Receptor Capping 3) |
| Protein Name | Neurogranin |
| UniProt ID | P84902 |
| Molecular Weight | ~8.7 kDa |
| Brain Expression | Hippocampus, Cortex |
| Cellular Localization | Postsynaptic dendritic spines |

Normal Physiological Function

Neurogranin plays several critical roles in synaptic plasticity[@derkach2007]:

Calmodulin Binding: Ng binds to calmodulin in the absence of calcium, regulating calmodulin availability for downstream signaling

Synaptic Plasticity: Involved in long-term potentiation (LTP) and memory formation

PKC Substrate: Major substrate for protein kinase C (PKC) phosphorylation

Dendritic Spine Morphogenesis: Regulates the structure and function of dendritic spines

Role as a Biomarker

CSF Neurogranin

...

Neurogranin (Ng)

Neurogranin (Ng) is a postsynaptic neuronal protein that serves as a sensitive biomarker for synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders[@portelius2015].

Overview

Neurogranin is a 78-amino acid protein encoded by the RC3 (RC3/Ng) gene, also known as neurogranin or RC3. It is highly enriched in dendritic spines of excitatory neurons in the hippocampus and cerebral cortex[@dazmoreno2010]. As a biomarker, neurogranin reflects the loss of synaptic integrity, which is a hallmark of cognitive decline in neurodegenerative diseases.

Structure and Function

Molecular Characteristics

| Property | Value |
|----------|-------|
| Gene | RC3 (Receptor Capping 3) |
| Protein Name | Neurogranin |
| UniProt ID | P84902 |
| Molecular Weight | ~8.7 kDa |
| Brain Expression | Hippocampus, Cortex |
| Cellular Localization | Postsynaptic dendritic spines |

Normal Physiological Function

Neurogranin plays several critical roles in synaptic plasticity[@derkach2007]:

Calmodulin Binding: Ng binds to calmodulin in the absence of calcium, regulating calmodulin availability for downstream signaling

Synaptic Plasticity: Involved in long-term potentiation (LTP) and memory formation

PKC Substrate: Major substrate for protein kinase C (PKC) phosphorylation

Dendritic Spine Morphogenesis: Regulates the structure and function of dendritic spines

Role as a Biomarker

CSF Neurogranin

Cerebrospinal fluid (CSF) neurogranin levels are elevated in Alzheimer's disease and correlate with[@kvartsberg2015][@wellington2016]:

• Cognitive Decline: Higher CSF Ng predicts faster cognitive decline
• Synaptic Loss: Correlates with synaptic protein loss in AD brain
• Disease Progression: Increases with disease severity
• Diagnostic Utility: Helps differentiate AD from other dementias

Clinical Significance

| Condition | CSF Neurogranin Level | Clinical Interpretation |
|-----------|----------------------|------------------------|
| Alzheimer's Disease | ↑ Elevated | Synaptic loss, disease progression |
| MCI due to AD | ↑ Moderately elevated | Early synaptic dysfunction |
| Frontotemporal Dementia | Normal to slightly elevated | Less synaptic involvement |
| Parkinson's Disease | Normal | Minimal cortical synaptic loss |
| Healthy Controls | Low baseline | Normal synaptic integrity |

Mechanisms of Elevation

In neurodegenerative diseases, neurogranin is released into CSF due to[@blennow2010]:

Synaptic Degeneration: Loss of dendritic spines and synaptic terminals

Excitotoxicity: Glutamate-induced synaptic damage

Proteolytic Cleavage: Generation of neurogranin fragments

Blood-Brain Barrier Permeability: Increased leakage of synaptic proteins

Therapeutic Implications

As a Therapeutic Target

• Synaptic Protection: Strategies to preserve synaptic integrity may lower CSF Ng
• Drug Development: Ng levels used as biomarker in clinical trials
• Patient Stratification: High CSF Ng identifies patients with active synaptic loss

Clinical Trial Utility

Neurogranin is increasingly used as a biomarker in AD clinical trials[@mattsson2018]:

• Monoclonal antibodies targeting Aβ and tau
• Synaptic protective agents
• Anti-inflammatory therapies

Detection Methods

| Method | Sample | Advantages |
|--------|--------|------------|
| ELISA | CSF | High sensitivity, widely available |
| Simoa | CSF/Plasma | Ultra-sensitive, can detect in blood |
| Western Blot | CSF | Confirms protein identity |
| Mass Spectrometry | CSF | High specificity, multiplex capable |

Biomarker Validation Studies

Large-scale validation studies have confirmed neurogranin's utility as a biomarker for synaptic dysfunction in Alzheimer's disease. Multi-center studies have demonstrated the robustness of CSF neurogranin measurements across different assay platforms and laboratories. These studies have established standardized protocols for clinical implementation.

Comparison with Other Synaptic Biomarkers

Neurogranin complements other synaptic biomarkers including SNAP-25, synaptotagmin, and synaptophysin. While each marker provides unique insights into different aspects of synaptic pathology, neurogranin has shown particular sensitivity to Alzheimer's disease-related synaptic changes. The combination of multiple synaptic biomarkers may provide more comprehensive assessment of neurodegeneration.

Background

The study of Neurogranin (Ng) Synaptic Biomarker has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Synaptic Dysfunction Pathway

Biomarker Utility

| Stage | Neurogranin Level | Diagnostic Use |
|-------|-------------------|----------------|
| Healthy | Baseline | Control |
| Preclinical | Slight elevation | Risk indicator |
| MCI | Moderate elevation | Early detection |
| AD | High elevation | Disease confirmation |
| Progression | Increasing | Severity marker |

Synaptic Dysfunction Pathway

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy

External Links## Cross-Links

Related Pages

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Cerebrospinal Fluid Biomarkers](/biomarkers)
• [Phosphorylated Tau 181](/mechanisms/dopaminergic-neuron-vulnerability)
• [Neurofilament Light Chain](/mechanisms/dopaminergic-neuron-vulnerability)

Related Proteins

• [SNAP](/proteins/snap-25)
• [PSD](/mechanisms/dopaminergic-neuron-vulnerability)
• [CaMKII](/mechanisms/dopaminergic-neuron-vulnerability)

Synaptic Dysfunction Pathway

Biomarker Utility

| Stage | Neurogranin Level | Diagnostic Use |
|-------|-------------------|----------------|
| Healthy | Baseline | Control |
| Preclinical | Slight elevation | Risk indicator |
| MCI | Moderate elevation | Early detection |
| AD | High elevation | Disease confirmation |
| Progression | Increasing | Severity marker |

Synaptic Dysfunction Pathway

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy

References

• [UniProt - RC3](https://www.uniprot.org/uniprot/Q7RTV0)
• [PubMed - Neurogranin](https://pubmed.ncbi.nlm.nih.gov/?te

See

• Synaptic - Alzheimer's Disease
• Biomarkers

• Pathway Diagram

The following diagram shows the key molecular relationships involving Neurogranin (Ng) - Synaptic Biomarker discovered through SciDEX knowledge graph analysis: